RIP-TAs (3) and RIP-TAf (4) Rifampicin (60 mg) and NADH(lOO mg) were incubated with cell homogenates ofE. coli #49 at 37°C for 3 hours.15)
The reaction mixture was centrifuged, and the supernatant was freeze-dried. The dried mixture was extracted with Analyzed after the addition of NaCI. Tables   1-3. 271
Results and Discussion
The structures of RIP-TAs (3), RIP-TAf (4), and RIPTAp (5) were determined by comparison of the spectroscopic data with those of rifampicin (1)6) and RIPMb (2)13).
Positive and negative ion FAB MS data of RIP-TAs (3) indicated the molecular weight to be 1363, and the molecular formula was determined by HRFABMSto be C58H79N9O25P2 (Table 1 ). Taking into account that NADH was essential for the formation of RIP-TAs (3) from rifampicin (1) with E. coli #49 homogenates, the molecular formula of 3 was in accord with that expected for ADP- The signals due to the other protons and carbons in the spectra of RIP-TAs (3) were similar to those of RIP-Mb (2), indicating that the rest (/P_o-P= 1 8.3 Hz).21) Consequently, the structure of RIP-TAs was determined to be as shown in Figure 1 . The molecular weight and molecular formula of RIP-TAf (4) were the same as those of RIP-TAs (3), and the *H NMRsignal pattern of 4 was similar to that of 3 ( Table  2 ).17) From the following data, it was determined that RIPTAs (3) is a sodium salt and RIP-TAf(4) is the free form of 3. Compared with RIP-TAs (3), RIP-TAf (4) had fewer sodium adduct ion peaks in the positive and negative ion FAB MS spectra (Table 1) . Compounds 3 and 4 had the same Rf value on TLC developed with an NaCl-containing solvent. They also had the same retention time on HPLC with TFA-containing solvent (Experimental).
In the purification of the conversion products of rifampicin with E. coli #49 homogenates by HPLCwith a TFA-containing solvent, only RIP-TAf (4) was obtained. ADP-ribosylation of rifampicin (1) with E. coli #49 homogenates afforded RIP-TAs (3) and RIP-TAf(4) in good yield (about 72%).
The structure of RIP-TAp (5) was determined by comparison of the FABMSand NMRdata with those of RIP-Mb (2) and RIP-TAs (3) (Tables 1-3 ). The molecular formula of RIP-TAp (5) was determined to be C48H67N4O19P (MW 1034). The formula is consistent with a mono-phosphorylated RIP-Mb. The presence of a fibose- of RIP-Mb (2), RIP-TAs (3), and RIP-TAp (5) indicated that the stereochemistry at C-l' of these compounds is the same.
